2026 Global: Aesthetic Threads Market-Competitive Review (2032) report
Description
The 2026 Global: Aesthetic Threads Market-Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for aesthetic threads market by geography and historical trend. The scope of the report extends to sizing of the aesthetic threads market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
The aesthetic threads market features leading companies specializing in minimally invasive thread lift technologies, primarily using materials like polydioxanone (PDO), polycaprolactone (PCL), and poly-L-lactic acid (PLLA) for facial rejuvenation and collagen stimulation. Aptos International Ltd (or APTOS LLC) dominates with its pioneering resorbable and non-resorbable threads, such as Excellence Visage, offering superior facial contouring since 1996, and holds significant global revenue share through innovations in biocompatible designs. Croma-Pharma GmbH excels in absorbable PDO threads like Countourel with patented cone molding for stable tissue anchoring, bolstered by 2025 partnerships expanding U.S. distribution and international revenues from complementary fillers. Sinclair Pharma leverages a robust portfolio and strategic alliances for notable market revenue, focusing on suspension threads that command 65% segment share for effective sagging tissue lifts. Healux Corporation (or Healux Co., LTD) advances biocompatible technologies, securing substantial revenues via global adoption of rejuvenating threads that stimulate collagen without strong lifting. Metro Korea Co. Ltd. drives growth through expanding product lines and market penetration, particularly in Asia-Pacific's fast 12.38% CAGR region fueled by medical tourism and cultural aesthetics demand.
Additional key players include N-Finders Co. Ltd., which contributes via specialized cog and multi-thread designs for multidirectional anchoring, posting strong growth in cone geometry at 11.25% CAGR. Menarini Group (A. Menarini Industrie Farmaceutiche Riunite SRL) strengthens its position with innovative absorbable threads in a fragmented market, aligning with consolidation trends like Crown Laboratories' 2025 acquisitions enhancing integrated aesthetics portfolios. Medical Aesthetic Group and Illari Threads focus on niche suspension and rejuvenating segments, supporting the market's projection from USD 149.2 million in 2024 to USD 294 million by 2035 at 6.4% CAGR, driven by non-invasive procedure preferences. NovaThreads sets industry standards with barbed and smooth PDO variants, emphasizing quality control and U.S.-led North American dominance at 42.5-44.7% share, where advanced infrastructure and practitioner expertise prevail. Hans Biomed (HansBiomed Co., Ltd. or Hans Biomed USA, Inc.) gains traction with FDA-cleared MINT PDO lines for safety and longevity, appealing to clinics seeking 24-month collagen effects amid rising PLLA and PCL adoption.
These ten companies—Aptos, Croma-Pharma, Sinclair, Healux, Metro Korea, N-Finders, Menarini, Medical Aesthetic Group, Illari Threads, and NovaThreads (with Hans Biomed as a close contender)—navigate a competitive landscape marked by R&D in longer-lasting polymers and regional expansions, particularly Asia-Pacific's urbanization and disposable income surges. Suspension threads lead at 65% share for surgical-free lifts, while absorbable variants like PDO hold 86% revenue, propelled by social media awareness and regulatory approvals. Strategic moves, such as A-TOP Health Biotech's 2025 PCL launches and Corza Medical's patient-friendly innovations, underscore premium positioning, with North America sustaining leadership via consumer demand for quick-recovery treatments. Overall, market fragmentation favors innovators addressing chronic pain adjuncts and mental health-linked aesthetics, forecasting robust growth to USD 287-620 million by 2033-2034.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for aesthetic threads market by geography and historical trend. The scope of the report extends to sizing of the aesthetic threads market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
The aesthetic threads market features leading companies specializing in minimally invasive thread lift technologies, primarily using materials like polydioxanone (PDO), polycaprolactone (PCL), and poly-L-lactic acid (PLLA) for facial rejuvenation and collagen stimulation. Aptos International Ltd (or APTOS LLC) dominates with its pioneering resorbable and non-resorbable threads, such as Excellence Visage, offering superior facial contouring since 1996, and holds significant global revenue share through innovations in biocompatible designs. Croma-Pharma GmbH excels in absorbable PDO threads like Countourel with patented cone molding for stable tissue anchoring, bolstered by 2025 partnerships expanding U.S. distribution and international revenues from complementary fillers. Sinclair Pharma leverages a robust portfolio and strategic alliances for notable market revenue, focusing on suspension threads that command 65% segment share for effective sagging tissue lifts. Healux Corporation (or Healux Co., LTD) advances biocompatible technologies, securing substantial revenues via global adoption of rejuvenating threads that stimulate collagen without strong lifting. Metro Korea Co. Ltd. drives growth through expanding product lines and market penetration, particularly in Asia-Pacific's fast 12.38% CAGR region fueled by medical tourism and cultural aesthetics demand.
Additional key players include N-Finders Co. Ltd., which contributes via specialized cog and multi-thread designs for multidirectional anchoring, posting strong growth in cone geometry at 11.25% CAGR. Menarini Group (A. Menarini Industrie Farmaceutiche Riunite SRL) strengthens its position with innovative absorbable threads in a fragmented market, aligning with consolidation trends like Crown Laboratories' 2025 acquisitions enhancing integrated aesthetics portfolios. Medical Aesthetic Group and Illari Threads focus on niche suspension and rejuvenating segments, supporting the market's projection from USD 149.2 million in 2024 to USD 294 million by 2035 at 6.4% CAGR, driven by non-invasive procedure preferences. NovaThreads sets industry standards with barbed and smooth PDO variants, emphasizing quality control and U.S.-led North American dominance at 42.5-44.7% share, where advanced infrastructure and practitioner expertise prevail. Hans Biomed (HansBiomed Co., Ltd. or Hans Biomed USA, Inc.) gains traction with FDA-cleared MINT PDO lines for safety and longevity, appealing to clinics seeking 24-month collagen effects amid rising PLLA and PCL adoption.
These ten companies—Aptos, Croma-Pharma, Sinclair, Healux, Metro Korea, N-Finders, Menarini, Medical Aesthetic Group, Illari Threads, and NovaThreads (with Hans Biomed as a close contender)—navigate a competitive landscape marked by R&D in longer-lasting polymers and regional expansions, particularly Asia-Pacific's urbanization and disposable income surges. Suspension threads lead at 65% share for surgical-free lifts, while absorbable variants like PDO hold 86% revenue, propelled by social media awareness and regulatory approvals. Strategic moves, such as A-TOP Health Biotech's 2025 PCL launches and Corza Medical's patient-friendly innovations, underscore premium positioning, with North America sustaining leadership via consumer demand for quick-recovery treatments. Overall, market fragmentation favors innovators addressing chronic pain adjuncts and mental health-linked aesthetics, forecasting robust growth to USD 287-620 million by 2033-2034.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.